Multiple sclerosis relapse and Interstitial lung disease
Summary:
Interstitial lung disease is found among people with Multiple sclerosis relapse, especially for people who are male, 40-49 old.
The study analyzes which people have Interstitial lung disease with Multiple sclerosis relapse. It is created by eHealthMe based on reports of 13 people who have Multiple sclerosis relapse from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Multiple sclerosis relapse?
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,033 drugs and 943 conditions by eHealthMe. Check the latest studies of Multiple sclerosis relapse.
What is Interstitial lung disease?
Interstitial lung disease is found to be associated with 1,499 drugs and 1,840 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.
13 people who have Multiple Sclerosis Relapse and Interstitial Lung Disease are studied.

Gender of people who have Multiple Sclerosis Relapse and experienced Interstitial Lung Disease *:
- female: 41.67 %
- male: 58.33 %
Age of people who have Multiple Sclerosis Relapse and experienced Interstitial Lung Disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 9.09 %
- 30-39: 27.27 %
- 40-49: 63.64 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 69.23%
- Osteoporosis (bones weak and more likely to break): 7 people, 53.85%
- Constipation: 7 people, 53.85%
- Back Pain: 7 people, 53.85%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 7.69%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 7.69%
- Nosebleed (bleeding from nose): 1 person, 7.69%
- Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 1 person, 7.69%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
- Blood Sodium Decreased: 1 person, 7.69%
Common drugs taken by these people *:
- Solu-Medrol: 9 people, 69.23%
- Depakene: 7 people, 53.85%
- Lioresal: 7 people, 53.85%
- Diazepam: 6 people, 46.15%
- Prednisolone: 6 people, 46.15%
- Gilenya: 5 people, 38.46%
- Zonisamide: 3 people, 23.08%
- Magnesium Oxide: 3 people, 23.08%
- Clarithromycin: 3 people, 23.08%
- Famotidine: 3 people, 23.08%
Common symptoms for these people *:
- White Blood Cell Count Decreased: 8 people, 61.54%
- Rashes (redness): 8 people, 61.54%
- Hypertrophy (increase in the volume of an organ or tissue due to the enlargement of its component cells): 7 people, 53.85%
- Moraxella Infection (bacterial infection): 7 people, 53.85%
- Lymphoproliferative Disorder (a medical condition in which the immune system makes too many white blood cells): 7 people, 53.85%
- Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 7 people, 53.85%
- Lymphangioma (tumour of lymph nodes): 7 people, 53.85%
- Lung Neoplasm (tumour of lung): 7 people, 53.85%
- Liver Disorder (liver diseases): 7 people, 53.85%
- Lipoma (a growth of fatty tissue that slowly develops just under your skin): 7 people, 53.85%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Interstitial lung disease?
- Check whether Interstitial lung disease is associated with a drug or a conditionRelated publications that referenced our studies
- Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
- Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
- Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
- Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Multiple sclerosis relapse (89,124 reports)
- Interstitial lung disease (69,102 reports)
All the drugs that are associated with Interstitial lung disease:
- Interstitial lung disease (1,499 drugs)
All the conditions that are associated with Interstitial lung disease:
- Interstitial lung disease (1,840 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Interstitial lung disease and Multiple sclerosis relapse, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Budesonide cause Confusion? - 2 seconds ago
- Could Albuterol cause Generalized Anxiety Disorder? - 8 seconds ago
- Could Tarceva cause Acute Myocardial Infarction? - 9 seconds ago
- Could Lisinopril cause Peritonitis? - 21 seconds ago
- Drug interactions of Oxycodone and Glyxambi - 37 seconds ago
- How effective is Cimzia for Psoriatic Arthritis? - 53 seconds ago
- Remeron vs. Symbyax, side effect and effectiveness comparison - a minute ago
- Insomnia and Toxic Skin Eruption - a minute ago
- Drug interactions of Zomig and Hydramine - a minute ago
- Could Cozaar cause Hepatic Pain? - a minute ago